These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 15582585

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Proteochemometric mapping of the interaction of organic compounds with melanocortin receptor subtypes.
    Lapinsh M, Veiksina S, Uhlén S, Petrovska R, Mutule I, Mutulis F, Yahorava S, Prusis P, Wikberg JE.
    Mol Pharmacol; 2005 Jan; 67(1):50-9. PubMed ID: 15470082
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Change of melanocortin receptor expression in rat kidney ischemia-reperfusion injury.
    Lee YS, Park JJ, Chung KY.
    Transplant Proc; 2008 Sep; 40(7):2142-4. PubMed ID: 18790174
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Constitutive homo- and hetero-oligomerization of TbetaRII-B, an alternatively spliced variant of the mouse TGF-beta type II receptor.
    Krishnaveni MS, Hansen JL, Seeger W, Morty RE, Sheikh SP, Eickelberg O.
    Biochem Biophys Res Commun; 2006 Dec 22; 351(3):651-7. PubMed ID: 17078931
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Preferential formation of MT1/MT2 melatonin receptor heterodimers with distinct ligand interaction properties compared with MT2 homodimers.
    Ayoub MA, Levoye A, Delagrange P, Jockers R.
    Mol Pharmacol; 2004 Aug 22; 66(2):312-21. PubMed ID: 15266022
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Probing the existence of G protein-coupled receptor dimers by positive and negative ligand-dependent cooperative binding.
    Albizu L, Balestre MN, Breton C, Pin JP, Manning M, Mouillac B, Barberis C, Durroux T.
    Mol Pharmacol; 2006 Nov 22; 70(5):1783-91. PubMed ID: 16926282
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Evidence indicating that the TM4, EL2, and TM5 of the melanocortin 3 receptor Do not participate in ligand binding.
    Schiöth HB, Muceniece R, Szardenings M, Prusis P, Wikberg JE.
    Biochem Biophys Res Commun; 1996 Dec 24; 229(3):687-92. PubMed ID: 8954958
    [Abstract] [Full Text] [Related]

  • 18. Homo- and hetero-dimeric complex formations of the human oxytocin receptor.
    Devost D, Zingg HH.
    J Neuroendocrinol; 2004 Apr 24; 16(4):372-7. PubMed ID: 15089977
    [Abstract] [Full Text] [Related]

  • 19. Aza-scanning of the potent melanocortin receptor agonist Ac-His-D-Phe-Arg-Trp-NH.
    Boeglin D, Xiang Z, Sorenson NB, Wood MS, Haskell-Luevano C, Lubell WD.
    Chem Biol Drug Des; 2006 Apr 24; 67(4):275-83. PubMed ID: 16629825
    [Abstract] [Full Text] [Related]

  • 20. Mechanism of dimerization of the human melanocortin 1 receptor.
    Zanna PT, Sánchez-Laorden BL, Pérez-Oliva AB, Turpín MC, Herraiz C, Jiménez-Cervantes C, García-Borrón JC.
    Biochem Biophys Res Commun; 2008 Apr 04; 368(2):211-6. PubMed ID: 18222116
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.